^
    Apply
    OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial) (NCT04389229)
    Phase 1/2
    Immetacyte Ltd
    Withdrawn
    Last update posted :
    12/15/2020
    Initiation :
    07/01/2020
    Primary completion :
    03/31/2023
    Completion :
    07/31/2025
    IL2
    |
    cyclophosphamide • fludarabine IV • Proleukin (aldesleukin) • CoTIL-01 • UTIL-01 • cyclophosphamide intravenous